Lehmann D - Search Results

1

Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis.

Lehmann D, Ben-Nun A. Lehmann D, et al. J Autoimmun. 1992 Dec;5(6):675-90. doi: 10.1016/0896-8411(92)90185-s. J Autoimmun. 1992. PMID: 1489483

2

Immunomodulation of experimental autoimmune myasthenia gravis with linomide.

Karussis DM, Lehmann D, Brenner T, Wirguin I, Mizrachi-Koll R, Sicsic C, Abramsky O. Karussis DM, et al. Among authors: lehmann d. J Neuroimmunol. 1994 Dec;55(2):187-93. doi: 10.1016/0165-5728(94)90009-4. J Neuroimmunol. 1994. PMID: 7829669

3

Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals.

Ben-Nun A, Liblau RS, Cohen L, Lehmann D, Tournier-Lasserve E, Rosenzweig A, Zhang JW, Raus JC, Bach MA. Ben-Nun A, et al. Among authors: lehmann d. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2466-70. doi: 10.1073/pnas.88.6.2466. Proc Natl Acad Sci U S A. 1991. PMID: 1706524 Free PMC article.

4

Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis.

Ben-Nun A, Yossefi S, Lehmann D. Ben-Nun A, et al. Among authors: lehmann d. Eur J Immunol. 1993 Mar;23(3):689-96. doi: 10.1002/eji.1830230318. Eur J Immunol. 1993. PMID: 8095458

5

Linomide activates the adrenocortical axis in the rat: inhibition of experimental autoimmune encephalomyelitis by linomide is not related to the increase of corticosterone.

Weidenfeld J, Karussis D, Abramsky O, Lehmann D, Arbell I, Ovadia H. Weidenfeld J, et al. Among authors: lehmann d. J Neuroimmunol. 1997 Oct;79(1):49-53. doi: 10.1016/s0165-5728(97)00121-5. J Neuroimmunol. 1997. PMID: 9357446

6

Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.

Lehmann D, Karussis DM, Fluresco D, Mizrachi-Koll R, Ovadia H, Shezen E, Kalland T, Abramsky O. Lehmann D, et al. J Neuroimmunol. 1997 Apr;74(1-2):102-10. doi: 10.1016/s0165-5728(96)00211-1. J Neuroimmunol. 1997. PMID: 9119961

7

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Kalland T, Abramsky O. Karussis DM, et al. Among authors: lehmann d. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6400-4. doi: 10.1073/pnas.90.14.6400. Proc Natl Acad Sci U S A. 1993. PMID: 8341645 Free PMC article.

8

Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis.

Lehmann D, Karussis D, Misrachi-Koll R, Shezen E, Ovadia H, Abramsky O. Lehmann D, et al. J Neuroimmunol. 1994 Feb;50(1):35-42. doi: 10.1016/0165-5728(94)90212-7. J Neuroimmunol. 1994. PMID: 8300856

9

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Ben-Nun A, Kalland T, Abramsky O. Karussis DM, et al. Among authors: lehmann d. Ann Neurol. 1993 Nov;34(5):654-60. doi: 10.1002/ana.410340506. Ann Neurol. 1993. PMID: 8239559

10

Immunomodulation of autoimmunity by linomide.

Karussis DM, Lehmann D, Slavin S, Kalland T, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Abramsky O. Karussis DM, et al. Among authors: lehmann d. Isr J Med Sci. 1995 Jan;31(1):38-41. Isr J Med Sci. 1995. PMID: 7836046 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results